Loading clinical trials...
Loading clinical trials...
Bladder cancer that has not invaded the bladder muscle often returns after treatment, creating repeated procedures and ongoing anxiety for patients. The standard initial treatment is transurethral res...
Keep your clinical trial research organized — questions to ask, what to expect, and key details.
Lead Sponsor
Lahore General Hospital
NCT07206225 · Non-muscle Invasive Bladder Cancer
NCT04389632 · Carcinoma, Non-Small Cell Lung, Squamous Cell Carcinoma of Head and Neck, and more
NCT07322263 · Bladder Cancer, Non-Muscle Invasive Bladder Cancer (NMIBC), and more
NCT06510374 · Intermediate Risk Non-Muscle Invasive Bladder Cancer
NCT07495072 · Urinary Bladder Neoplasms, BCG-Induced Cystitis
Lahore General Hospital, Lahore
Lahore, Punjab Province
Use Clareo to keep notes, questions, trial details, and next steps organized before and after appointments.
Start free trial →Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and Conditions